ING5 inhibits cancer aggressiveness via preventing EMT and is a potential prognostic biomarker for lung cancer.
about
ING5 suppresses breast cancer progression and is regulated by miR-24Targeting inhibition of extracellular signal-regulated kinase kinase pathway with AZD6244 (ARRY-142886) suppresses growth and angiogenesis of gastric cancer.ING5 inhibits epithelial-mesenchymal transition in breast cancer by suppressing PI3K/Akt pathway.MicroRNA-130b improves renal tubulointerstitial fibrosis via repression of Snail-induced epithelial-mesenchymal transition in diabetic nephropathyMiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expressionThe down-regulated ING5 expression in lung cancer: a potential target of gene therapy.Down-regulation of MALAT1 inhibits cervical cancer cell invasion and metastasis by inhibition of epithelial-mesenchymal transition.INGs are potential drug targets for cancer.The roles of ING5 in gliomas: a good marker for tumorigenesis and a potential target for gene therapy.ING5 knockdown enhances migration and invasion of lung cancer cells by inducing EMT via EGFR/PI3K/Akt and IL-6/STAT3 signaling pathways.Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.The nucleocytoplasmic translocation and up-regulation of ING5 protein in breast cancer: a potential target for gene therapy.CEACAM6 is a prognostic biomarker and potential therapeutic target for gastric carcinoma.The roles of ING5 expression in ovarian carcinogenesis and subsequent progression: a target of gene therapy.ING5 activity in self-renewal of glioblastoma stem cells via calcium and follicle stimulating hormone pathways.ING5 differentially regulates protein lysine acetylation and promotes p300 autoacetylation.ING5-mediated antineuroblastoma effects of suberoylanilide hydroxamic acid
P2860
Q33654764-2B0FC416-4C9F-4899-AEDB-6A262949D51CQ36280358-E026607D-899D-4242-A2A1-4291FA5E2460Q36317550-5FE2E166-B1EE-4933-ABBD-7AFF0069D672Q36536375-C5435929-0279-433D-8305-61D479F66FF7Q37584834-A83EF703-487E-47D5-AE88-DEDE6CAD5CECQ37688109-FDF5336E-ACE1-428E-B8FA-71E179CFC5B9Q38451967-AAF7C0BD-F6B4-4AFE-8667-002F18DFB5C8Q38932782-8FF46A5C-2EA3-4529-AB60-D3EC52500949Q41345808-C7189018-7B66-46ED-8743-40D63F8A9736Q41552636-CA415C05-05F2-4F85-BE75-62DC8F8AB7ADQ42005326-12E3DFF3-B16C-4146-B21F-D722D63E95A2Q45874456-B1CCCA29-D244-4826-91F2-B04908ECF808Q46303343-EA8A52F9-E443-43F1-830A-0061562C31C8Q47094216-21890FF6-3304-4F6D-980E-BF7F57D41BE7Q47962979-8A1B369F-E2A0-44B3-9793-19559C180102Q49423163-C71596B6-99BD-4F19-A0D7-A12D8496ADF4Q58792092-09EBADAE-C7AD-45B7-AA03-FDC2B44F4946
P2860
ING5 inhibits cancer aggressiveness via preventing EMT and is a potential prognostic biomarker for lung cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
ING5 inhibits cancer aggressiv ...... tic biomarker for lung cancer.
@ast
ING5 inhibits cancer aggressiv ...... tic biomarker for lung cancer.
@en
type
label
ING5 inhibits cancer aggressiv ...... tic biomarker for lung cancer.
@ast
ING5 inhibits cancer aggressiv ...... tic biomarker for lung cancer.
@en
prefLabel
ING5 inhibits cancer aggressiv ...... tic biomarker for lung cancer.
@ast
ING5 inhibits cancer aggressiv ...... tic biomarker for lung cancer.
@en
P2093
P2860
P356
P1433
P1476
ING5 inhibits cancer aggressiv ...... tic biomarker for lung cancer.
@en
P2093
Feng Zhang
Qibing Mei
Xutao Zhang
Yanxia Liu
P2860
P304
16239-16252
P356
10.18632/ONCOTARGET.3842
P407
P577
2015-06-01T00:00:00Z